By in silico analysis of a cohort of NSCLCs and normal lung tissues, we first found that all four members of the TBX2 subfamily were, overall, hypermethylated, at both promoter regions and CpG islands, in clinical NSCLC samples compared to normal lung. Here, TBX2 is linked to non-small cell lung carcinoma.